Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Rob Deering participating in the Yorkshire marathon

Interviews

Comedian Rob Deering on raising nearly £100,000 for Parkinson’s UK

"I’ve run nine marathons to raise money for Parkinson’s"

READ MORE
Tim Peake Walter Reynecke

Global update

Astronaut in space tweets praise to the delight of Parkinson’s painter

Painter is over the moon to receive recognition from astronaut

READ MORE

Advances

Scientists ‘revive’ foetal implant treatment for Parkinson’s

Foetal cells are injected into a man's brain to 'cure' his Parkinson's

READ MORE